Abstract
Diabetes is a multifactorial disease, the pathogenesis of which involves participation of the host immune system in beta cell destruction. Studies on identical twins offer the opportunity to define genetic and non-genetic factors which may contribute to susceptibility to the disease. Our own work indicates that the number and nature, as well as the intensity and persistence of immune abnormalities of cellular and humoral immune responses can be powerful predictors of the disease and also identify twins who have a degree of protection from the disease.
Full text
PDF


Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Alviggi L., Johnston C., Hoskins P. J., Tee D. E., Pyke D. A., Leslie R. D., Vergani D. Pathogenesis of insulin-dependent diabetes: a role for activated T lymphocytes. Lancet. 1984 Jul 7;2(8393):4–6. doi: 10.1016/s0140-6736(84)91994-9. [DOI] [PubMed] [Google Scholar]
- Baekkeskov S., Aanstoot H. J., Christgau S., Reetz A., Solimena M., Cascalho M., Folli F., Richter-Olesen H., De Camilli P., Camilli P. D. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature. 1990 Sep 13;347(6289):151–156. doi: 10.1038/347151a0. [DOI] [PubMed] [Google Scholar]
- Baekkeskov S., Nielsen J. H., Marner B., Bilde T., Ludvigsson J., Lernmark A. Autoantibodies in newly diagnosed diabetic children immunoprecipitate human pancreatic islet cell proteins. Nature. 1982 Jul 8;298(5870):167–169. doi: 10.1038/298167a0. [DOI] [PubMed] [Google Scholar]
- Bingley P. J., Gale E. A. Incidence of insulin dependent diabetes in England: a study in the Oxford region, 1985-6. BMJ. 1989 Mar 4;298(6673):558–560. doi: 10.1136/bmj.298.6673.558. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bingley P. J., Gale E. A. Rising incidence of IDDM in Europe. Diabetes Care. 1989 Apr;12(4):289–295. doi: 10.2337/diacare.12.4.289. [DOI] [PubMed] [Google Scholar]
- Bottazzo G. F., Dean B. M., McNally J. M., MacKay E. H., Swift P. G., Gamble D. R. In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. N Engl J Med. 1985 Aug 8;313(6):353–360. doi: 10.1056/NEJM198508083130604. [DOI] [PubMed] [Google Scholar]
- Christie M. R., Tun R. Y., Lo S. S., Cassidy D., Brown T. J., Hollands J., Shattock M., Bottazzo G. F., Leslie R. D. Antibodies to GAD and tryptic fragments of islet 64K antigen as distinct markers for development of IDDM. Studies with identical twins. Diabetes. 1992 Jul;41(7):782–787. doi: 10.2337/diab.41.7.782. [DOI] [PubMed] [Google Scholar]
- Christie M. R., Vohra G., Champagne P., Daneman D., Delovitch T. L. Distinct antibody specificities to a 64-kD islet cell antigen in type 1 diabetes as revealed by trypsin treatment. J Exp Med. 1990 Sep 1;172(3):789–794. doi: 10.1084/jem.172.3.789. [DOI] [PMC free article] [PubMed] [Google Scholar]
- De Berardinis P., Londei M., Kahan M., Balsano F., Kontiainen S., Gale E. A., Bottazzo G. F., Feldmann M. The majority of the activated T cells in the blood of insulin-dependent diabetes mellitus (IDDM) patients are CD4+. Clin Exp Immunol. 1988 Aug;73(2):255–259. [PMC free article] [PubMed] [Google Scholar]
- Feldmann M., June C. H., McMichael A., Maini R., Simpson E., Woody J. N. T-cell-targeted immunotherapy. Immunol Today. 1992 Mar;13(3):84–85. doi: 10.1016/0167-5699(92)90146-X. [DOI] [PubMed] [Google Scholar]
- Greenbaum C. J., Palmer J. P. Insulin antibodies and insulin autoantibodies. Diabet Med. 1991 Feb-Mar;8(2):97–105. doi: 10.1111/j.1464-5491.1991.tb01553.x. [DOI] [PubMed] [Google Scholar]
- Johnston C., Alviggi L., Millward B. A., Leslie R. D., Pyke D. A., Vergani D. Alterations in T-lymphocyte subpopulations in type I diabetes. Exploration of genetic influence in identical twins. Diabetes. 1988 Nov;37(11):1484–1488. doi: 10.2337/diab.37.11.1484. [DOI] [PubMed] [Google Scholar]
- Lendrum R., Walker G., Gamble D. R. Islet-cell antibodies in juvenile diabetes mellitus of recent onset. Lancet. 1975 Apr 19;1(7912):880–882. doi: 10.1016/s0140-6736(75)91683-9. [DOI] [PubMed] [Google Scholar]
- Lernmark A. Islet cell antibodies. Diabet Med. 1987 Jul-Aug;4(4):285–292. doi: 10.1111/j.1464-5491.1987.tb00881.x. [DOI] [PubMed] [Google Scholar]
- Lo S. S., Tun R. Y., Hawa M., Leslie R. D. Studies of diabetic twins. Diabetes Metab Rev. 1991 Dec;7(4):223–238. doi: 10.1002/dmr.5610070403. [DOI] [PubMed] [Google Scholar]
- Peakman M., Hussain M. J., Millward B. A., Leslie R. D., Vergani D. Effect of initiation of insulin therapy on T-lymphocyte activation in type 1 diabetes. Diabet Med. 1990 May;7(4):327–330. doi: 10.1111/j.1464-5491.1990.tb01399.x. [DOI] [PubMed] [Google Scholar]
- Roep B. O., Arden S. D., de Vries R. R., Hutton J. C. T-cell clones from a type-1 diabetes patient respond to insulin secretory granule proteins. Nature. 1990 Jun 14;345(6276):632–634. doi: 10.1038/345632a0. [DOI] [PubMed] [Google Scholar]
- Roep B. O., Kallan A. A., Hazenbos W. L., Bruining G. J., Bailyes E. M., Arden S. D., Hutton J. C., de Vries R. R. T-cell reactivity to 38 kD insulin-secretory-granule protein in patients with recent-onset type 1 diabetes. Lancet. 1991 Jun 15;337(8755):1439–1441. doi: 10.1016/0140-6736(91)93127-u. [DOI] [PubMed] [Google Scholar]
- Smerdon R. A., Peakman M., Hussain M. J., Alviggi L., Watkins P. J., Leslie R. D., Vergani D. Increase in simultaneous coexpression of naive and memory lymphocyte markers at diagnosis of IDDM. Diabetes. 1993 Jan;42(1):127–133. doi: 10.2337/diab.42.1.127. [DOI] [PubMed] [Google Scholar]
- Todd J. A. Genetic control of autoimmunity in type 1 diabetes. Immunol Today. 1990 Apr;11(4):122–129. doi: 10.1016/0167-5699(90)90049-f. [DOI] [PubMed] [Google Scholar]
